Governance Committees. The term “Governance Committees” shall have the meaning ascribed to it in Section 7.01 of this Agreement.
Governance Committees. Further to the introduction to Boards and Committees of the University, the University will recognise the importance of and support the representation of the student voice at its committees throughout the academic year. The university will ensure the SU is involved in the setting of the agenda, and that the nominated representative receives all papers allowing sufficient time to prepare for the meeting. This may include consultation with other SU Officers and representatives prior to the meeting. Sabbatical officers will be given the opportunity to send SU Reports on an as-needed basis.
Governance Committees. The Parties shall establish (a) a Joint Steering Committee (“JSC”) to oversee and coordinate the overall conduct of all Programs hereunder; (b) a Joint Research Committee (“JRC”) to oversee and coordinate discovery, research and pre-clinical Development activities with respect to each Program until nomination of a Development Candidate for such Program; (c) a Joint Development Committee (“JDC”) for each Program as to which a Development Candidate has been nominated and designated and for which Celgene retains an Opt-In Right; (d) a Joint Commercialization Committee (“JCC”) to oversee Commercialization activities under a Development & Commercialization Agreement; and (e) a Joint Patent Committee (“JPC”) to oversee Patent Prosecution and enforcement (the JSC, the JRC, the JDC, the JCC and the JPC shall each be referred to as a “Committee”). Each Committee shall have decision-making authority with respect to the matters within its purview to the extent expressly and as more specifically provided herein; it being understood and agreed that (i) notwithstanding anything to the contrary contained herein, on a Program-by-Program basis, from and after the date that Vividion provides a Vividion Opt-Out Notice, the Committees shall no longer have any decision-making authority with respect to such Program, but shall continue to function for information sharing purposes until the applicable Vividion Opt-Out Date (each as defined in Appendix A-1 or Xxxxxxxx X-0, as applicable) and (ii) with respect to any Program that is subject to an executed License Agreement, no Committee shall have any review or decision-making authority.
Governance Committees. The Parties shall establish (a) a Joint Development Committee (“JDC”) to oversee Development of Emricasan in the Research Field during the Research Term and (b) a Joint Partnering Committee (“JPC”) to oversee Commercialization activities for the Products. The JDC and JPC shall have decision-making authority with respect to the matters within its purview to the extent expressly and as more specifically provided herein, it being understood and agreed that with respect to any Product that becomes subject to a Qualifying Strategic Partnership, neither the JDC nor JPC shall have any review or decision-making authority as of the effective date thereof with respect to such Product(s).
Governance Committees. The Parties hereby establish (i) a Joint Steering Committee (“JSC”) to oversee and coordinate the overall conduct of all further activities concerning the Collaboration after the Effective Date; (ii) a Joint Development Committee (“JDC”) to oversee and coordinate Development (including Manufacturing of clinical supply) of the Licensed Product(s); (iii) a Joint Commercialization Committee (“JCC”) to oversee the Commercialization (including Manufacturing of commercial supply) of the Licensed Products; (iv) the Joint Patent Committee (“JPC”) to coordinate the Prosecution of Agios Patent Rights, Agios Collaboration Patent Rights, Celgene Patent Rights and Celgene Collaboration Patent Rights (the JSC, the JDC, the JCC and JPC shall each be referred to as a “Committee”); and (v) a joint Finance Working Group (“Finance Working Group”) to coordinate financial aspects of the Collaboration and to act as a resource for all financial matters for each Committee as needed. Each Committee may from time to time establish subcommittees or project teams to handle matters within the scope of its authority. From and after the Effective Date, no “Committee” or other working group established under the 2010 Agreement shall have the authority to address any matters involving this Collaboration.
Governance Committees. The Parties will form the following committees which will be responsible for the matters described as follows (as may be amended during the Term as mutually agreed in writing by the Parties):
Governance Committees. The Parties shall establish a Joint Steering Committee (“JSC”) to oversee and coordinate the overall Collaboration hereunder. The JSC shall have decision-making authority with respect to the matters within its purview to the extent expressly and as more specifically provided herein, it being understood and agreed that notwithstanding anything to the contrary contained herein, from and after the date that BioAtla provides a Co-Development Opt-Out Notice, the JSC shall no longer have any decision-making authority with respect to the Candidates and/or the Products, but shall continue to function solely for information sharing purposes.
Governance Committees. Member agrees to take part in cooperative governance by availing him/her/itself to vote on matters for which Class M members are eligible to vote, and to volunteer and serve on Committees, as may be made available from time to time by the Board of Directors, and applicable.
Governance Committees. The Parties agree as follows with respect to the System Executive Committee and System Operations Committee established pursuant to Section 4.03 of the Radio System Agreement:
Governance Committees
